LON:SCLP Scancell (SCLP) Share Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range 9.41▼ 14.5052-Week Range N/AVolume1.13 million shsAverage Volume518,717 shsMarket Capitalization£132.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get Scancell alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Scancell Stock (LON:SCLP)Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, ovarian, renal, and head and neck cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.Read More Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here SCLP Stock News HeadlinesJuly 19, 2024 | americanbankingnews.comScancell (LON:SCLP) Trading Up 8.3%May 1, 2024 | morningstar.comScancell Holdings PLC SCLPJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.March 4, 2024 | finance.yahoo.comWith 47% stake, Scancell Holdings plc (LON:SCLP) seems to have captured hedge funds investors' interestFebruary 23, 2024 | benzinga.comScancell Holdings Stock (OTC:SCNLF), Insider Trading ActivityJanuary 22, 2024 | lse.co.ukScancell Holdings Share ChatJanuary 4, 2024 | proactiveinvestors.comScancell: US investment bank resumes coverage with punchy price targetDecember 18, 2023 | uk.finance.yahoo.comScancell Holdings plc (SCP.F)July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.December 13, 2023 | finance.yahoo.comThe past year for Scancell Holdings (LON:SCLP) investors has not been profitableDecember 1, 2023 | proactiveinvestors.comScancell fundraiser brings in £10.7m after it is 'upsized'November 2, 2023 | proactiveinvestors.comAnalysts encouraged by Scancell’s strong year-end trading statementNovember 1, 2023 | proactiveinvestors.comScancell melanoma trial data chosen for poster presentation at SITCOctober 31, 2023 | uk.investing.comScancell makes strong progress with lead immunotherapy assetsOctober 2, 2023 | uk.news.yahoo.comScancell shares are on fire! Should I buy?September 25, 2023 | finance.yahoo.comHedge funds investors are Scancell Holdings plc's (LON:SCLP) biggest bettors and were rewarded after last week's UK£25m market cap gainSeptember 20, 2023 | finance.yahoo.comScancell CEO hails "exciting" high response rate to melanoma treatmentSeptember 19, 2023 | proactiveinvestors.comScancell jumps 23% after trial data; analysts hail resultsSee More Headlines Receive SCLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/31/2020Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SCLP CUSIPN/A CIKN/A Webwww.scancell.co.uk Phone+44-115-8231863FaxN/AEmployees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-9,530,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-269.84% Return on Assets-37.22% Debt Debt-to-Equity Ratio61.41 Current Ratio8.63 Quick Ratio13.01 Sales & Book Value Annual Sales£5.27 million Price / Sales24.94 Cash FlowGBX 1.80 per share Price / Cash Flow7.86 Book ValueGBX (1) per share Price / Book-14.15Miscellaneous Outstanding Shares928,980,000Free FloatN/AMarket Cap£131.45 million OptionableNot Optionable Beta0.37 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesProf. Lindy Gillian Durrant Ph.D. (Age 67)Founder, CEO, Chief Scientific Officer & Director Comp: $369.12kDr. Sally Elizabeth Adams (Age 63)Executive Officer Comp: $253.51kMr. Sathijeevan Nirmalananthan (Age 38)CFO & Director Dr. Samantha Paston Ph.D.Head of Translational ResearchDr. Adrian Parry Ph.D.Head of ManufacturingDr. Mandeep SehmiHead of Business DevelopmentDr. Callum ScotthasbeenHead of DevelopmentMr. Keith Charles GreenCompany SecretaryMore ExecutivesKey CompetitorsSilence TherapeuticsLON:SLNPureTech HealthLON:PRTCOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDAvacta GroupLON:AVCTView All Competitors SCLP Stock Analysis - Frequently Asked Questions How have SCLP shares performed this year? Scancell's stock was trading at GBX 10.50 at the beginning of the year. Since then, SCLP stock has increased by 35.7% and is now trading at GBX 14.25. View the best growth stocks for 2024 here. How were Scancell's earnings last quarter? Scancell Holdings plc (LON:SCLP) posted its quarterly earnings results on Friday, January, 31st. The company reported ($0.56) earnings per share for the quarter. How do I buy shares of Scancell? Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Scancell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scancell investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Petropavlovsk (POG), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO) and Empyrean Energy (EME). This page (LON:SCLP) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scancell Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Scancell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
